- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Acute hepatic porphyria
- Meeting Date: July 2025
- Public Summary Document (PSD) July 2025 PBAC Meeting - (PDF)
- Public Summary Document (PSD) July 2025 PBAC Meeting - (Word)
Givosiran – July 2025
Givosiran; Solution for injection 189 mg in 1 mL; Givlaari®
Last updated
9 July 2025